Serological Tests. Hemagglutination tests were performed according to the method of Stimpfling (8) in a modification described previously (9) . Cytotoxic test in microplates was carried out as described elsewhere (10) using splenocytes as target cells and normal guinea pig serum as a source of complement, and estimating the percentages of killed cells by means of phase contrast microscope. Quantitative absorptions were performed by the techniques described by Snell et al. (11) . Briefly, lymphocytes from spleen and lymph nodes were distributed into a series of five tubes in such a way that the first tube contained 8 × l0 s (or in some cases 32 × 10 e) cells, and the subsequent tubes doubling dilutions of the initial suspension. Antiserum was added to each tube in a volume that gave a final concentration corresponding to that giving 80% of dead cells in a regular titration of the antiserum. The mixtures were incubated for 30 min, then centrifuged and the supernates tested for residual cytotoxicity. The concentration of cells in the initial suspension was determined by three This work was supported by U. S. Public Health Service research grant AIl1879.
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Results
Bailey et al. (1) , as well as other investigators, made several attempts to produce alloantisera using the congenic pair of B6 and B6.C-H(zl), but failed. We failed to produce antibodies in the following strain combinations: B6 --, M505, M505 --* B6, M505 -~ (B10 x C3H)F~, using different immunization regimens and a variety of serological tests. We also failed to differentiate the H-2 ba and H-2 ~ haplotypes from the H-2 ~ haplotype using a battery of oligospecific antisera against known H-2 antigens. In all instances, antigens present in the H-2 ~ haplotype were found to be present in the two mutant haplotypes, and vice versa. However, in tests involving antiserum K-30, a slight quantitative difference in cytotoxic reactivity was observed between H-2 b on the one hand and ba and bd on the other hand. The suggested difference was then explored in detail using the quantitative absorption technique.
Antiserum K-30 was produced in combination (B10.D2 × A)F~ anti-HTI or d/a anti-/and should contain antibodies against the private antigen controlled by the H-2K b allele (antigen H-2.33). It could also contain antibodies against non-H-2 antigens; however, since the critical strains used in our experiments were of the same genetic background, only H-2 antibodies could be detected. Theoretically, the antiserum could contain antibodies against the /-region-associated (Ia) antigens. Since the Ia antigens are expressed strongly on one population of lymphocytes (usually B cells), the antiserum was absorbed with different numbers of T cells (to remove H-2 antibodies) and then tested against B cells (to detect Ia antibodies), or vice versa. However, in all experiments absorption by T (B) cells always removed all activity against B (T) cells, suggesting that the only antibodies present in the antiserum were those against H-2 antigens. Panel test of the antiserum (Table I) revealed presence of two antibodies, one against antigen H-2.33 and another against unidentified antigen shared by strains C57BL/10Sn(H-2~), B10.S(H-2 ~) and probably also DBA/1 (H-2q). Absorption by B10.S cells removed the B10.S and DBA/1 reactivity but did not significantly affect the B6, Hzl, or M505 reactivity.
Quantitative absorption of antiserum K-30 by lymphocytes from B6, Hzl, M505, and B10.D2 strains was repeated 6 times, always with similar result: approximately 2.5 times more Hzl or M505 than B6 cells were required to reduce the cytotoxicity of the antiserum against B6 cells to 50% (Fig. 1 ). This effect was specific, since antibodies against antigen H-2.2, the private antigen of the H-2D ~ gene unaffected by the two mutations, were absorbed to an equal extent by b, ba, and bd cells (Fig. 2) .
Discussion
These observations indicate that the anti-H-2.33 absorptive capacity of the ba and bd cells is lower than that of the b cells. The decrease in the absorptive capacity of the mutant cells can principally be explained in two ways: first, the two mutations were of a regulatory type and as such merely decreased the content of H-2.33 on the cell surface; second, the mutations occurred outside of the H-2.33 site and modified this site only indirectly. The first explanation is contradicted by the fact that both mutations elicit graft rejection, MLR and 
B10.A(3R) i3 + + + + + + + +

B10.A(5R) i5 + + + + + + + +
B10.A(R107) i7 + + + + + + + +
B10.A(R106)
ia + + + + + + B10.WB ja -- -- B10.BR k -- -- B10.AKM m -- -- DBA/1 q + + -- DA qpl -- -- B10.RIII(71NS) r -- -- B10.S s + + A.TL tl --
B10.S(7R)
t2 -- CML when tested in combination with the H-2 ~ strain, indicating that the mutational change was qualitative rather than quantitative. Thus, the serological observations indicate quantitative, and the cellular immunity studies qualitative alterations caused by the two mutations. It seems to us that the simplest way to reconcile these seemingly contradictory results is to postulate that the serologically detectable site (recognized by B cells) and the site detectable by cellular reactions (recognized by T cells) are located in different portions of the same molecule. The mutations occurred in the site detectable by cellular immunity and changed the conformation of the H-2 molecule in such a way that it lowered the capacity of the serologically detectable site to bind anti-H-2.33 antibodies (the change in the primary structure of the H-2 molecule affected the cellular immunity site, and the change in the tertiary structure affected the serologically detectable site). Alternatively, one can postulate that in both H-2 ba and H-2 b~ two mutations occurred simultaneously in two different genes, one coding for the serologically detectable antigens and another for antigens detected by cellular immunity. However, such an event is highly unlikely in the case of point mutations.
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The findings on the H-2 mutations challenge the commonly held view that the serologically detectable H-2 antigens are identical with antigens eliciting cellular immunity. Such a view is probably a misconception (for discussion see ref. 6 ) and more likely the relationship between the two types of antigens can be interpreted in terms of hapten-carrier interaction (for discussion see ref. 12) .
The absorption data indicate that both the H-2 b~ and H-2 ~ mutations occurred in the H-2K b gene rather than in one of the genes located in the I region. From this observation two important conclusions can be drawn. First, the H-2K antigens are capable of causing significant MLR; second, induction of CML across the H-2K locus difference does not require simultaneous difference in the I region. These conclusions are supported by the findings with a third mutation, H-2 ~ (6); they contradict the hypothesis of SD-LD polarization of major histocompatibility complexes (13) , as well as the hypothesis of specific K and I region cooperation in the development of CML (7) .
While this work was being completed, a manuscript by Apt and co-workers (5) 
